Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
साल्ट लेक सिटी, टोरंटो और मॉन्ट्रियल, July 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), औषधि खोज को औद्योगिक बनानेवाली एक अग्रणी क्लिनिकल स्टेज TechBio कंपनी ने, आज NVIDIA द्वारा $50...
-
SALT LAKE CITY, TORONTO et MONTRÉAL, 13 juill. 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), société biotechnologique au stade clinique chef de file dans le décodage biologique pour...
-
SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery,...
-
TORONTO, 11 juill. 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), une société chef de file spécialisée dans la biotechnologie en stade clinique qui décode les données biologiques afin...
-
TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today celebrated the opening of its...
-
SALT LAKE CITY, June 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the full...
-
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
-
SALT LAKE CITY, May 25, 2023 (GLOBE NEWSWIRE) -- Altitude Lab announced today that its incubator program and facility will leave Research Park to grow its operation in the Gateway’s BioHive hub as...
-
SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed...
-
SALT LAKE CITY y TORONTO y MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), una empresa líder de tecnobiología en etapa clínica con la decodificación de biología para la...